{"id":630,"date":"2016-03-01T13:22:05","date_gmt":"2016-03-01T12:22:05","guid":{"rendered":"http:\/\/ibtherapeutics.com\/?page_id=630"},"modified":"2026-02-19T11:44:12","modified_gmt":"2026-02-19T10:44:12","slug":"agenda","status":"publish","type":"page","link":"https:\/\/ibtherapeutics.com\/sv\/investerare\/agenda\/","title":{"rendered":"Kalendarium"},"content":{"rendered":"

2026<\/h1>\n

6 februari 2026, kl 07:30<\/h2>\n

Bokslutskommunik\u00e9 jan-dec 2025<\/p>\n

27 Mars 2026, kl 07:30<\/h2>\n

\u00c5rsredovisning 2025<\/p>\n

6 maj 2026, kl 14:00<\/h2>\n

Del\u00e5rsrapport jan-mar 2026<\/p>\n

7 maj 2026, kl 16:00<\/h2>\n

\u00c5rsst\u00e4mma 2026<\/p>\n

26 augusti 2026, kl 07:30<\/h2>\n

Del\u00e5rsrapport apr-jun 2026<\/p>\n

13 november 2026, kl 07:30<\/h2>\n

Del\u00e5rsrapport jul-sep 2026<\/p>\n

2025<\/h1>\n

13 februari 2025, kl 08:30<\/h2>\n

Bokslutskommunik\u00e9 january – december 2024<\/p>\n

Mars 2025<\/h2>\n

\u00c5rsredovisning 2024<\/p>\n

7 maj 2025, kl 14:30<\/h2>\n

Del\u00e5rsrapport januari-mars 2025<\/p>\n

8 maj 2025 kl 16:00-18:00<\/h2>\n

\u00c5rsst\u00e4mma IBT<\/p>\n

20 augusti 2025, kl 08:30<\/h2>\n

Del\u00e5rsrapport april-juni 2025<\/p>\n

13 november 2025<\/h2>\n

Del\u00e5rsrapport juli-september 2025<\/p>\n

2024<\/h1>\n

8 februari 2024<\/h2>\n

Bokslutskommunik\u00e9 2023<\/p>\n

7 maj 2024 kl 16:00<\/h2>\n

Del\u00e5rsrapport januari \u2013 mars 2024<\/p>\n

8 maj 2024<\/h2>\n

\u00c5rsst\u00e4mma 2024<\/p>\n

28 augusti 2024 kl 08:30<\/h2>\n

Del\u00e5rsrapport januari \u2013 juni 2024<\/p>\n

14 november 2024 kl 08:30<\/h2>\n

Del\u00e5rsrapport juli – september 2024<\/p>\n

2023<\/h1>\n

10 februari 2023<\/h2>\n

Bokslutskommunik\u00e9 2022<\/p>\n

8 maj 2023<\/h2>\n

Del\u00e5rsrapport kvartal 1<\/p>\n

8 maj 2023<\/h2>\n

\u00c5rsst\u00e4mma<\/p>\n

25 augusti 2023<\/h2>\n

Del\u00e5rsrapport\u00a0kvartal 2<\/p>\n

10 november 2023<\/h2>\n

Del\u00e5rsrapport\u00a0kvartal 3<\/p>\n

2022<\/h1>\n

19 januari 2022<\/h2>\n

SEB Healthcare Seminar 2022<\/p>\n

4 februari 2022<\/h2>\n

Bokslutskommunik\u00e9 januari-december 2021<\/p>\n

15-17 mars 2022<\/h2>\n

Carnegie Healthcare Seminar 2022<\/p>\n

mars 2022<\/h2>\n

\u00c5rsredovisning 2021<\/p>\n

21-25 april 2022<\/h2>\n

Pediatric Academic Societies Meeting<\/p>\n

4 maj 2022<\/h2>\n

Del\u00e5rsrapport januari-mars 2022<\/p>\n

\u00c5rsst\u00e4mma 2022<\/p>\n

8-9 juni 2022<\/h2>\n

Handelsbanken Nordic Mid \/ Small Cap Seminar 2022<\/p>\n

6-7 juli 2022<\/h2>\n

Microbiome Connect Europe 2022<\/p>\n

25 augusti 2022<\/h2>\n

Del\u00e5rsrapport januari-juni 2022<\/p>\n

\n

7-8 september 2022<\/h2>\n<\/div>\n
Pareto Securities’ Healthcare Conference<\/div>\n

10 november 2022<\/h2>\n

Del\u00e5rsrapport januari-september 2022<\/p>\n

2021<\/h1>\n

20 januari 2021<\/em><\/h2>\n

SEB Healthcare Seminar 2021<\/p>\n

5 februari 2021<\/em><\/h2>\n

Bokslutskommunik\u00e9 2020, 08.00 CET<\/p>\n

11 mars 2021 <\/em><\/h2>\n

Carnegie Nordic Virtual Healthcare Seminar<\/p>\n

Vecka 14 2021<\/em><\/h2>\n

\u00c5rsredovisning 2020<\/p>\n

28 april 2021<\/em><\/h2>\n

Redeye Orphan Drugs Seminar<\/p>\n

1-4 maj 2021<\/em><\/h2>\n

Pediatric Academic Societies Meeting<\/p>\n

4 maj 2021<\/em><\/h2>\n

\u00c5rst\u00e4mma f\u00f6r IBT. Sista datum att beg\u00e4ra att f\u00e5 \u00e4rende behandlat p\u00e5 \u00e5rsst\u00e4mman \u00e4r 10 april 2021.<\/p>\n

Del\u00e5rsrapport januari-mars 2021, kl 08.00 CET<\/p>\n

25 maj 2021<\/em><\/h2>\n

ABG Life Science Day<\/p>\n

<\/h2>\n

2 juni 2021<\/em><\/h2>\n

Handelsbanken Nordic Mid \/ Small Cap Seminar 2021<\/p>\n

<\/h2>\n

13 augusti 2021<\/em><\/h2>\n

Del\u00e5rsrapport januari-juni 2021, 08.00 CET<\/p>\n

<\/h2>\n

2 september 2021<\/em><\/h2>\n

Pareto Healthcare Seminar<\/p>\n

30 september 2021<\/em><\/h2>\n

Erik Penser Bank Temadag S\u00e4rl\u00e4kelmedel<\/p>\n

29 oktober 2021<\/em><\/h2>\n

Del\u00e5rsrapport januari-september 2021, 08.00 CET<\/p>\n

<\/h2>\n

2020<\/h1>\n

7-8 JANUARY 2020<\/em><\/h2>\n

SEB Nordic Seminar, Copenhagen<\/p>\n

22 JANUARI 2020<\/em><\/h2>\n

SEB Pharma & Biotech Seminar, Stockholm<\/p>\n

11 februari 2020<\/em><\/h2>\n

Bokslutskommunik\u00e9 2019, 08.00 CET<\/p>\n

3 MARS 2020<\/em><\/h2>\n

Carnegie Nordic Healthcare Seminar, Stockholm<\/p>\n

Vecka 14 2020<\/em><\/h2>\n

\u00c5rsredovisning 2019<\/p>\n

11 maj 2020<\/em><\/h2>\n

Del\u00e5rsrapport januari-mars 2020, kl 16.00 CET<\/p>\n

16 juni 2020<\/em><\/h2>\n

\u00c5rst\u00e4mma 2019. Sista datum att beg\u00e4ra att f\u00e5 \u00e4rende behandlat p\u00e5 \u00e5rsst\u00e4mman \u00e4r 1 april 2020.<\/p>\n

14 augusti 2020<\/em><\/h2>\n

Del\u00e5rsrapport januari-juni 2020, 08.00 CET<\/p>\n

2-3 september 2020<\/em><\/h2>\n

Pareto Securities’ Healthcare Conference<\/p>\n

5 NOVEMBER 2020<\/em><\/h2>\n

Del\u00e5rsrapport januari-september 2020, 08.00 CET<\/p>\n

2019<\/h1>\n

8 februari 2019<\/em><\/h2>\n

Bokslutskommunik\u00e9 2018, 08.00 CET<\/p>\n

27 mars 2019<\/em><\/h2>\n

Stifel Nordic Day, London<\/p>\n

4 april 2019<\/em><\/h2>\n

\u00c5rsredovisning 2018<\/p>\n

6 maj 2019<\/em><\/h2>\n

Del\u00e5rsrapport januari-mars 2019<\/p>\n

\u00c5rst\u00e4mma f\u00f6r IBT kommer att h\u00e5llas den 6 maj 2019 kl 15.00 i\u00a0Svenska L\u00e4kares\u00e4llskapet lokaler p\u00e5 Klara \u00d6stra Kyrkogata 10, Stockholm.\u00a0Sista datum att beg\u00e4ra att f\u00e5 \u00e4rende behandlat p\u00e5 \u00e5rsst\u00e4mman \u00e4r 1 april 2019.<\/p>\n

2-5 juni 2019<\/em><\/h2>\n

NEC Society Symposium, Ann Arbor, Michigan<\/p>\n

21 augusti 2019<\/em><\/h2>\n

Del\u00e5rsrapport januari-juni 2019, 08.00 CET<\/p>\n

7 november 2019<\/em><\/h2>\n

Del\u00e5rsrapport januari-september 2019, 08.00 CET<\/p>\n

20-21 november 2019<\/em><\/h2>\n

Jefferies 2019 London Healthcare Conference<\/p>\n

25-26 november 2019<\/em><\/h2>\n

Nordea Innovation Seminar, Stockholm<\/p>\n

2018<\/h2>\n

28 februari 2018<\/em><\/h2>\n

Bokslutskommunik\u00e9 2017<\/p>\n

15 mars 2018<\/em><\/h2>\n

Carnegie Nordic Healthcare Seminar 2018, Stockholm<\/p>\n

12 april 2018<\/em><\/h2>\n

\u00c5rsredovisning 2017<\/p>\n

15 maj 2018<\/em><\/h2>\n

Del\u00e5rsrapport januari-mars 2018<\/p>\n

\u00c5rsst\u00e4mma f\u00f6r IBT kommer att h\u00e5llas den 15 maj 2018 kl 15.00 i Citykonferensen Ingenj\u00f6rshuset, Malmskillnadsgatan 46, Stockholm. Sista datum att beg\u00e4ra att f\u00e5 \u00e4rende behandlat p\u00e5 \u00e5rsst\u00e4mman \u00e4r 28 mars 2018.<\/p>\n

16 augusti 2018\u00a0<\/em><\/h2>\n

Del\u00e5rsrapport januari-juni 2018<\/p>\n

6 september 2018<\/em><\/h2>\n

Pareto Securities Health Care Conference, Stockholm<\/p>\n

14 november 2018<\/em><\/h2>\n

Del\u00e5rsrapport januari-september 2018<\/p>\n

27 november 2018<\/em><\/h2>\n

Nordea Tech & Medtech Seminar, Stockholm<\/p>\n

29 november\u00a02018<\/em><\/h2>\n

Nordic-American Life Science Conference, New York<\/p>\n

\n

\u00a0
<\/span>2017<\/h2>\n<\/div>\n

april 2017<\/em><\/h2>\n

\u00c5rsredovisning\u00a02016<\/p>\n

maj 4, 2017<\/em><\/h2>\n

\u00c5rsst\u00e4mma h\u00e5lls torsdagen den 4 maj 2017 kl. 14.00 i Citykonferensen Ingenj\u00f6rshuset, Malmskillnadsgatan 46, Stockholm.<\/p>\n

Del\u00e5rsrapport januari-mars 2017<\/p>\n

augusti 28, 2017<\/em><\/h2>\n

Del\u00e5rsrapport januari-juni\u00a02017<\/p>\n

september 7, 2017<\/em><\/h2>\n

Pareto Securities 8:e \u00e5rliga h\u00e4lsov\u00e5rdsseminarium i Stockholm<\/p>\n

september 8, 2017<\/em><\/h2>\n

Kapitalmarknadsdag<\/h3>\n

Infant Bacterial Therapeutics har n\u00f6jet att bjuda in investerare, analytiker och media att delta i v\u00e5r kapitalmarknadsdag i Stockholm den 8 september 2017.\u00a0Arrangemanget \u00e4ger rum p\u00e5 Svenska L\u00e4kares\u00e4llskapet, Klara \u00d6stra Kyrkogata 10, Stockholm mellan kl. 9.30 och kl. 12.00.<\/p>\n

Syftet med kapitalmarknadsdagen \u00e4r att presentera Infant Bacterial Therapeutics verksamhet, sjukdomen necrotiserande enterocolit, IBP-9414-projektet, gastroschisis och IBP-1016-projektet.<\/p>\n

november 23, 2017<\/em><\/h2>\n

Del\u00e5rsrapport januari-september 2017<\/p>\n","protected":false},"excerpt":{"rendered":"

2026 6 februari 2026, kl 07:30 Bokslutskommunik\u00e9 jan-dec 2025 27 Mars 2026, kl 07:30 \u00c5rsredovisning 2025 6 maj 2026, kl 14:00 Del\u00e5rsrapport jan-mar 2026 7 maj 2026, kl 16:00 \u00c5rsst\u00e4mma 2026 26 augusti 2026, kl 07:30 Del\u00e5rsrapport apr-jun 2026 13 november 2026, kl 07:30 Del\u00e5rsrapport jul-sep 2026 2025 13 februari 2025, kl 08:30 Bokslutskommunik\u00e9 january […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":622,"menu_order":43,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/630"}],"collection":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=630"}],"version-history":[{"count":88,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/630\/revisions"}],"predecessor-version":[{"id":4391,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/630\/revisions\/4391"}],"up":[{"embeddable":true,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/622"}],"wp:attachment":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}